Not applicableUnknownNCT01104324What this trial is testingOsteonecrosis in Children With Acute Lymphoblastic LeukemiaWho this might be right forOsteonecrosisAcute Lymphoblastic Leukemia Halton, Jacqueline, M.D. 130
Testing effectiveness (Phase 2)Study completedNCT00930098What this trial is testingA Phase II, Open-Label Study of Clofarabine in Paediatric Patients With Refractory/Relapsed Acute Lymphoblastic LeukaemiaWho this might be right forAcute Lymphoblastic Leukemia Genzyme, a Sanofi Company 74
Large-scale testing (Phase 3)Study completedNCT03123939What this trial is testingPhase III B in Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Novartis Pharmaceuticals 69
Not applicableLooking for participantsNCT07634653What this trial is testingStrength Training Exercise in Pediatric Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (STEP-ALL)Who this might be right forLeukemiaAcute LeukemiaAcute Lymphoid Leukemia+2 more UNC Lineberger Comprehensive Cancer Center 40
Testing effectiveness (Phase 2)Study completedNCT00186875What this trial is testingTherapy for Pediatric Relapsed or Refractory Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaLymphoma, Lymphoblastic St. Jude Children's Research Hospital 47
Not applicableStudy completedNCT01901367What this trial is testingALL-Active: A Family-Based Lifestyle Program for Pediatric Acute Leukemia PatientsWho this might be right forChildhood Acute Lymphoblastic Leukemia in Remission Vanderbilt-Ingram Cancer Center 33
Not applicableLooking for participantsNCT06323044What this trial is testingMedSupport Intervention to Identify and Address Barriers to Pediatric Medication AdherenceWho this might be right forAcute Lymphoblastic Leukemia Roswell Park Cancer Institute 150
Testing effectiveness (Phase 2)WithdrawnNCT05320380What this trial is testingThe Drug IMGN632 in Children With Leukemia That Has Come Back After Treatment or is Difficult to TreatWho this might be right forRecurrent Acute Myeloid LeukemiaRecurrent B Acute Lymphoblastic LeukemiaRecurrent Mixed Phenotype Acute Leukemia+5 more Children's Oncology Group
Testing effectiveness (Phase 2)Active Not RecruitingNCT02028455What this trial is testingA Pediatric and Young Adult Trial of Genetically Modified T Cells Directed Against CD19 for Relapsed/Refractory CD19+ LeukemiaWho this might be right forCD19+ Acute Leukemia Seattle Children's Hospital 167
Early research (Phase 1)WithdrawnNCT05168748What this trial is testingCD19- and CD22-directed CAR-T Cell Therapy in Patients With Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic Leukemia Novartis Pharmaceuticals
Not applicableStudy completedNCT06389357What this trial is testingRetun-to-school Adaptation Program for Children With CancerWho this might be right forChildhood CancerALL, ChildhoodAML, Childhood+2 more Gazi University 20
Early research (Phase 1)Looking for participantsNCT06080191What this trial is testingAllogeneic Second-generation CD19-CAR T Cells for Pediatric Relapsed/Refractory B-ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Bambino Gesù Hospital and Research Institute 24
Testing effectiveness (Phase 2)Active Not RecruitingNCT07134088What this trial is testingSubcutaneous Blinatumomab in Children With R/R and and MRD+ B-Cell Precursor Acute Lymphoblastic LeukemiaWho this might be right forRelapsed/Refractory B-Cell Precursor Acute Lymphoblastic LeukemiaMinimal Residual Disease + B-Cell Acute Lymphoblastic Leukemia Amgen 104
Not applicableStudy completedNCT03471416What this trial is testingNutritional Status in Children With ALL in GuatemalaWho this might be right forAcute Lymphoblastic Leukemia Columbia University 109
Not applicableStudy completedNCT03655587What this trial is testingImpact of an Orthotic Intervention in Children With Peripheral NeuropathyWho this might be right forGait, Drop FootChemotherapy-induced Peripheral NeuropathyAcute Lymphocytic Leukemia, Pediatric+2 more Children's Hospitals and Clinics of Minnesota 27
Large-scale testing (Phase 3)UnknownNCT04228393What this trial is testingThe Individualized Treatment of 6-mercaptopurine in Children With Acute Lymphoblastic Leukemia in ChinaWho this might be right forAcute Lymphoblastic Leukemia, Pediatric Wei Zhao 82
Not applicableNot Yet RecruitingNCT07374315What this trial is testingWeight Gain in Pediatric Leukemia SurvivorsWho this might be right forLeukemiaPediatric Acute Lymphoblastic LeukemiaPediatric Acute Lymphoblastic Leukemia in Remission+1 more Washington University School of Medicine 80
Early research (Phase 1)Active Not RecruitingNCT02650414What this trial is testingCD22 Redirected Autologous T Cells for ALLWho this might be right forB Cell LeukemiasB Cell Lymphomas University of Pennsylvania 41
Testing effectiveness (Phase 2)Looking for participantsNCT05745714What this trial is testingHEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological MalignanciesWho this might be right forAcute Lymphoblastic Leukemia, in RelapseLymphoblastic Lymphoma (Precursor B-Lymphoblastic Lymphoma/Leukaemia) RecurrentLymphoblastic Lymphoma (Precursor T-Lymphoblastic Lymphoma/Leukaemia) Recurrent+2 more Princess Maxima Center for Pediatric Oncology
Testing effectiveness (Phase 2)Looking for participantsNCT07387926What this trial is testingSafety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)Who this might be right forAcute Lymphoblastic LeukemiaLeukemia, Lymphoblastic, Acute, Philadelphia-PositivePhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia Novartis Pharmaceuticals 50